Absentia Labs, Inc

From the company

Absentia Labs is building AI foundation models that predict how medicines behave inside the human body, aiming to transform biology from an experimental science into a predictive one. The company develops AI systems that learn from biological, chemical, and clinical data to model drug behavior, predict safety and efficacy, and accelerate decision-making across the drug development pipeline. Its Digital Liver Model became the first AI drug development tool accepted into an FDA qualification program.